Analysis questions clinical benefit of PCI in stable CAD

A meta-analysis of eight trials found that PCI had no clinical benefit over standard medical therapy in cases of stable coronary artery disease. However, physicians pointed out there is little new information in the report and raised concerns about the study's design. "This is largely old news, and many interventional cardiologists are avoiding the pitfalls that the [study] authors are pointing out," said SCAI Advocacy Committee Chair Dr. James Blankenship. Blankenship, SCAI Vice President Dr. Ted Bass and SCAI member Dr. Ajay Kirtane discussed PCI's role in non-acute cases. "For many people, conservative medical therapy is the right thing, but for those who have a lot of symptoms, having a coronary intervention is a reasonable strategy," Blankenship said. Bass made similar points, adding that "the bottom line is that clinicians want to practice evidence-based medicine and provide the best care to our patients. That's what we care about."

View Full Article in:

HealthDay News · TheHeart.org (Montreal) (free registration) · New York Times (tiered subscription model), The · TCTMD.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA